Genetic Variability and Clinical Spectrum of Chinese Patients with Limb‐girdle Muscular Dystrophy Type 2A

Su-Shan Luo,Jian-Ying Xi,Wen-Hua Zhu,Chong-Bo Zhao,Jia-Hong Lu,Jie Lin,Yin Wang,Jun Lu,Kai Qiao
DOI: https://doi.org/10.1002/mus.23381
2012-01-01
Muscle & Nerve
Abstract:Introduction: Previous studies of limb-girdle muscular dystrophy type 2A (LGMD2A) patients in many countries have suggested a heterogeneous genetic and clinical spectrum, but the genotypes and phenotypes of Chinese LGMD2A patients remain unclear. Methods: We directly screened calpain-3 (CAPN3) in 18 Chinese Han subjects who exhibited severely reduced or completely absent calpain-3 expression, as determined by Western blot analysis. We subsequently analyzed genotype/phenotype correlations. Results: Seventeen patients (94.4%) were identified who had at least 1 causative mutation. All 18 mutations were distributed along the entire gene, and 11 of the mutations were novel, including 4 missense mutations, 5 deletions, and 2 splicing mutations. The phenotypes of these Chinese LGMD2A patients varied from severe LGMD to distal myopathy, and even asymptomatic hyper-CK-emia. Conclusions: No evidential correlation was found between the genotypes and phenotypes of the patients assessed in this study. Western blot analysis is still a useful diagnostic method when genetic analysis is unavailable. Muscle Nerve, 2012
What problem does this paper attempt to address?